IJRR

International Journal of Research and Review

| Home | Current Issue | Archive | Instructions to Authors | Journals |

Year: 2024 | Month: September | Volume: 11 | Issue: 9 | Pages: 277-283

DOI: https://doi.org/10.52403/ijrr.20240929

A Single Blind Randomized Control Study to Endeavor the Effect of Wiesbaden Dilution 30C in the Treatment of Telogen Effluvium

Syeda Safa Samreen1, Dr. Shilpa Patil2, Dr. T Surekha3, Dr. Justina Steefan3

2Department of Repertory & Case taking, 3Department of Community Medicine, 344Department of Psychiatry MNR Homoeopathic Medical College & Hospital, Kaloji Narayan Rao University of Health Sciences, Sangareddy, India.

Corresponding Author: Syeda Safa Samreen

ABSTRACT

Background and Objective: Telogen effluvium is a hair shedding disorder, which is characterized by an abnormal increase in the amount of hair shed from the scalp.
The current study is aimed at finding the effectiveness of Wiesbaden Dilution 30C in managing Telogen Effluvium using Hairpull test
Methods: A study at MNR Homoeopathic Medical College assessed 550-600 students experiencing excessive hair fall (100+ hairs/day). 60 severe cases with positive hair pull tests were selected based on inclusion/exclusion criteria. Randomized into two groups (odd/even method):
Group A (n=30): Wiesbaden 30C once/week for 4 months
Group B (n=30): Placebo once/week for 4 months
Hair pull tests were conducted at baseline and monthly intervals. Patient progress was monitored for 4 months.
Results: Efficacy of Wiesbaden 30C was evaluated by comparing pre- and post-treatment hair pull test results. Notably, 23 out of 30 patients (76.66%) in the Wiesbaden 30C group demonstrated significant reduction in hair fall, indicating substantial improvement.
Results highlighted 76.66% success rate in reducing hair fall, 23 patients showed significant improvement. Wiesbaden 30C treatment yielded promising outcomes
Conclusion: This study confirms Wiesbaden 30C's efficacy in treating Telogen Effluvium, with 76.66% success rate (23/30 cases), No adverse effects, New hair growth, including darker hairs. Most affected age group was18-25 with higher incidence in females. Clinical verification supports Wiesbaden 30C's effectiveness in managing Telogen Effluvium, irrespective of age and gender. Results suggest potential therapeutic benefits for excessive hair fall.

Keywords: Telogen Effluvium, Excessive Hair Fall, Homoeopathy, Hair Shedding Disorder, Wiesbaden 30C, Clinical Trial, Hair Fall Treatment

[PDF Full Text]